Related Experiment Videos

Interleukin-2 therapy with or without lymphokine-activated killer-cell infusions for low-grade non-Hodgkin's

R Levy, J M Tourani, J M Andrieu

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|August 1, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Observational study of vaccination in cancer patients: How can vaccine coverage be improved?

Medecine et maladies infectieuses·2019

Phase I dose-escalation study of oral vinflunine in combination with erlotinib in pre-treated and unselected EGFR patients with locally advanced or metastatic non-small-cell lung cancer.

Cancer chemotherapy and pharmacology·2013

Phase I dose-escalation study of oral vinflunine administered once daily for 6 weeks every 8 weeks in patients with advanced/metastatic solid tumours.

Cancer chemotherapy and pharmacology·2013

Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Supportive care organisation in France: an in depth study by the French speaking association for supportive care in cancer (AFSOS).

European journal of cancer (Oxford, England : 1990)·2012

See all related articles